161 related articles for article (PubMed ID: 34840986)
1. Potential Role of GST-
Wang W; Wei J; Tu X; Ye X
Biomed Res Int; 2021; 2021():9142364. PubMed ID: 34840986
[TBL] [Abstract][Full Text] [Related]
2. MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6.
Yang L; Lin Z; Wang Y; Gao S; Li Q; Li C; Xu W; Chen J; Liu T; Song Z; Liu G
Mol Carcinog; 2018 Mar; 57(3):419-428. PubMed ID: 29144562
[TBL] [Abstract][Full Text] [Related]
3. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
[TBL] [Abstract][Full Text] [Related]
4. [Increased expression of acetaldehyde dehydrogenase in cisplatin-resistant human lung adenocarcinoma A549/DDP cells].
He J; Song X; Yu L; Li J; Qiao Z; Jiu R; Yu B; Liu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):625-9. PubMed ID: 25940289
[TBL] [Abstract][Full Text] [Related]
5. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q
Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
7. Chemoresistant lung cancer stem cells display high DNA repair capability to remove cisplatin-induced DNA damage.
Yu WK; Wang Z; Fong CC; Liu D; Yip TC; Au SK; Zhu G; Yang M
Br J Pharmacol; 2017 Feb; 174(4):302-313. PubMed ID: 27933604
[TBL] [Abstract][Full Text] [Related]
8. [Reverse effect of genetically modified adenovirus H101 on drug-resistance of A549/DDP cells to cisplatin].
Xu RH; Yuan ZY; Guan ZZ; Li S
Ai Zheng; 2005 Aug; 24(8):975-9. PubMed ID: 16086876
[TBL] [Abstract][Full Text] [Related]
9. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
Wang W; Liu G; Zheng J
Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of stem cell markers and drug resistance in sphere-forming non-small cell lung cancer cells.
Sun FF; Hu YH; Xiong LP; Tu XY; Zhao JH; Chen SS; Song J; Ye XQ
Int J Clin Exp Pathol; 2015; 8(6):6287-300. PubMed ID: 26261505
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells.
Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J
Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026
[TBL] [Abstract][Full Text] [Related]
12. Effects of vinorelbine on cisplatin resistance reversal in human lung cancer A549/DDP cells.
Zhou YT; Li K; Tian H
Asian Pac J Cancer Prev; 2013; 14(8):4635-9. PubMed ID: 24083716
[TBL] [Abstract][Full Text] [Related]
13. Glutathione S‑transferase isozyme alpha 1 is predominantly involved in the cisplatin resistance of common types of solid cancer.
Zou M; Hu X; Xu B; Tong T; Jing Y; Xi L; Zhou W; Lu J; Wang X; Yang X; Liao F
Oncol Rep; 2019 Feb; 41(2):989-998. PubMed ID: 30431119
[TBL] [Abstract][Full Text] [Related]
14. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
Cai Y; Dong ZY; Wang JY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of TRAP1 promotes cisplatin-induced apoptosis by promoting the ROS-dependent mitochondrial dysfunction in lung cancer cells.
Zhang X; Dong Y; Gao M; Hao M; Ren H; Guo L; Guo H
Mol Cell Biochem; 2021 Feb; 476(2):1075-1082. PubMed ID: 33196942
[TBL] [Abstract][Full Text] [Related]
16. Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling.
Su J; Wu S; Tang W; Qian H; Zhou H; Guo T
Mol Carcinog; 2016 Nov; 55(11):1822-1832. PubMed ID: 26513225
[TBL] [Abstract][Full Text] [Related]
17. PRDM14 mediates chemosensitivity and glycolysis in drug‑resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells.
He S; Ma X; Zheng N; Wang G; Wang M; Xia W; Yu D
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355367
[TBL] [Abstract][Full Text] [Related]
18. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway.
Jiang P; Xu H; Xu C; Chen A; Chen L; Zhou M; Haq IU; Wu X; Mariyam Z; Feng Q
Chem Biol Interact; 2018 Dec; 296():154-161. PubMed ID: 30291867
[TBL] [Abstract][Full Text] [Related]
19. [Antitumor effects of chemotherapeutic drugs on fresh human gastric cancer cells and their relationships to expressions of P-glycoprotein and glutathione S transferase-pi].
Zhang J; Ji J; Ji YB; Yuan F; Liu BY; Zhu ZG; Lin YZ
Ai Zheng; 2005 Apr; 24(4):432-7. PubMed ID: 15820065
[TBL] [Abstract][Full Text] [Related]
20. Mutated p53 Promotes the Symmetric Self-Renewal of Cisplatin-Resistant Lung Cancer Stem-Like Cells and Inhibits the Recruitment of Macrophages.
Xu Y; Xu Z; Li Q; Guo L; Wang Y; Zhou J; Wang G; Liu Y
J Immunol Res; 2019; 2019():7478538. PubMed ID: 31781681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]